If you represent a Multiple Sclerosis research study and would like to post the study on mscare.org, please click here to download a trial information form. Upon completing the form, please email it to us at or fax to (201) 678-2290.

For more information on listing a study, please contact us at . Trial listings are free of charge as a service to the Multiple Sclerosis Community. Click here to view this latest section in our website.

Special Guidelines and Studies:

• May 19, 2009 -2009 Consortium of MS Centers MRI Protocol for the Diagnosis and Follow-up of MS

• May 27, 2009 -Houston Neurologist, Dr. Victor Rivera Receives CMSC Lifetime Achievement Award for his Contributions to the Field of Multiple Sclerosis Research and Treatment 
• May 27, 2009 -International Experts in MS Care Convene in Atlanta for Annual Meeting 
• May 27, 2009 -MSWorld, Inc. Launches Online Cognitive-Based Memory Video Game on Inaugural World MS Day 

• June 24, 2009 -Merck Serono Launches RebiSmart, First Electronic Injection Device for Delivery of Multiple Sclerosis Treatment Rebif 
• June 19, 2009 -Many MS Patients Not Filling Prescriptions 
• June 8, 2009 -Acorda Therapeutics Announces Eligibility of Fampridine-SR for Centralized Review in Europe 
• May 28, 2009 -MS Patients Report Greater Treatment Satisfaction with TYSABRI® 
• April 30, 2009 -First Ten-Year Follow-Up Shows That Treatment with AVONEX ® Leads to Long-Term Benefits in Early Multiple Sclerosis Patients 
• April 29, 2009 -New Outcomes Study Reports TYSABRI® Patients Show Overall Improvement in Cognition and Quality of Life, With Lower Levels of Fatigue 
• April 28, 2009 -MRI Data Showing TYSABRI® Promoted Remyelination Presented at the 61st Annual Meeting of the American Academy of Neurology 
• April 23, 2009 -Acorda Therapeutics Resubmits New Drug Application for Fampridine-SR 
• April 21, 2009 -BioMS Medical's Pivotal International Multiple Sclerosis Trial Receives Positive Review from Data Safety Monitoring Board 
• April 16, 2009 -Biogen Idec Receives Approval for Tysabri High Titer Production 
• April 16, 2009 -Copaxone Approved by Health Canada for Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis 

• Headache and MS: Learning from Each Other
  Daniel M Kantor, MD 

• May 2009 -Abstracts from the 23rd Annual Meeting of CMSC